{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:22:55Z","timestamp":1780370575558,"version":"3.54.1"},"reference-count":43,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00406","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T00:13:24Z","timestamp":1498781604000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition"],"prefix":"10.3389","volume":"8","author":[{"given":"Melissa","family":"Skibba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Abdul","family":"Hye Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren L.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Falck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Amaradhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Imig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1476-5381.2010.01093.x","article-title":"Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury.","volume":"162","author":"Batchu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/35000034","article-title":"A: the transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.","volume":"2","author":"Batlle","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1074\/jbc.M113.508416","article-title":"The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt.","volume":"289","author":"Capdevila","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.2009.86","article-title":"Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.","volume":"75","author":"Chevalier","year":"2009","journal-title":"Kidney Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2353\/ajpath.2010.090898","article-title":"The origin of renal fibroblasts and progression of kidney disease.","volume":"176","author":"Cook","year":"2010","journal-title":"Am. J. Pathol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-10-94","article-title":"Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.","volume":"10","author":"Das","year":"2009","journal-title":"BMC Cell Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1021\/jm900634w","article-title":"14,15-epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition.","volume":"52","author":"Falck","year":"2009","journal-title":"J. Med. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"20202","DOI":"10.1074\/jbc.M110.102012","article-title":"Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis.","volume":"285","author":"Flier","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev.med.57.121304.131342","article-title":"Toward a unified theory of renal progression.","volume":"57","author":"Harris","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1042\/CS20150778","article-title":"Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.","volume":"130","author":"Hye Khan","year":"2016","journal-title":"Clin. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1096\/fj.12-218040","article-title":"Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity.","volume":"27","author":"Hye Khan","year":"","journal-title":"FASEB J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/HYPERTENSIONAHA.113.01949","article-title":"Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat.","volume":"62","author":"Hye Khan","year":"","journal-title":"Hypertension"},{"key":"B13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1042\/CS20130479","article-title":"Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition.","volume":"127","author":"Hye Khan","year":"2014","journal-title":"Clin. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/FJC.0b013e3181e96e0c","article-title":"Targeting epoxides for organ damage in hypertension.","volume":"56","author":"Imig","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology.","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2010.00157","article-title":"Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions.","volume":"1","author":"Imig","year":"2010","journal-title":"Front. Physiol."},{"key":"B17","article-title":"Compositions and methods for the treatment of renal and cardiovascular disease","author":"Imig","year":"2009"},{"key":"B18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"B19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ki.2014.235","article-title":"The contribution of epithelial-mesenchymal transition to renal fibrosis differs among kidney disease models.","volume":"87","author":"Inoue","year":"2015","journal-title":"Kidney Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","article-title":"Epithelial-mesenchymal transition and its implications for fibrosis.","volume":"112","author":"Kalluri","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0014-5793(90)81014-F","article-title":"Arachidonic acid epoxygenase. Stereochemical analysis of the endogenous epoxyeicosatrienoic acids of human kidney cortex.","volume":"268","author":"Karara","year":"1990","journal-title":"FEBS Lett."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-016-1365-6","article-title":"Valproic acid attenuates renal fibrosis through the induction of autophagy.","author":"Kawaoka","year":"2016","journal-title":"Clin. Exp. Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"F971","DOI":"10.1152\/ajprenal.00256.2014","article-title":"Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.","volume":"307","author":"Kim","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"F131","DOI":"10.1152\/ajprenal.00531.2014","article-title":"Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.","volume":"308","author":"Kim","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2353\/ajpath.2009.090698","article-title":"Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy.","volume":"175","author":"Kizu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2353\/ajpath.2007.061199","article-title":"Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice.","volume":"171","author":"Lange-Sperandio","year":"2007","journal-title":"Am. J. Pathol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047482","article-title":"Dioscorea alata attenuates renal interstitial cellular fibrosis by regulating Smad- and epithelial-mesenchymal transition signaling pathways.","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis.","volume":"18","author":"Liu","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"i37","DOI":"10.1093\/ndt\/gft267","article-title":"Transforming growth factor-beta and the progression of renal disease.","volume":"29","author":"Loeffler","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/cells4040631","article-title":"Epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction?","volume":"4","author":"Loeffler","year":"2015","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s13069-015-0030-0","article-title":"Novel approach for the detection of tubular cell migration into the interstitium during renal fibrosis in rats.","volume":"8","author":"Nakasatomi","year":"2015","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10565-008-9071-0","article-title":"Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase.","volume":"25","author":"Parrish","year":"2009","journal-title":"Cell Biol. Toxicol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8612190","article-title":"Effect of Huai Qi Huang on epithelial-mesenchymal transition of renal tubular epithelial cells through miR-200a.","volume":"2016","author":"Pu","year":"2016","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"B34","first-page":"407","article-title":"Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis.","volume":"19","author":"Rastaldi","year":"2006","journal-title":"J. Nephrol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050751","article-title":"Novel omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis.","volume":"17","author":"Sharma","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.ki.5002180","article-title":"Phenotypic transitions and fibrosis in diabetic nephropathy.","volume":"71","author":"Simonson","year":"2007","journal-title":"Kidney Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2174\/092986710790827843","article-title":"Epoxyeicosatrienoic acid analogs and vascular function.","volume":"17","author":"Sudhahar","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.HYP.0000090123.55365.BA","article-title":"Down regulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension.","volume":"42","author":"Wang","year":"2003","journal-title":"Hypertension"},{"key":"B39","doi-asserted-by":"publisher","first-page":"30591","DOI":"10.1016\/j.kint.2016.09.039","article-title":"Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.","volume":"91","author":"Wu","year":"2016","journal-title":"Kidney Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1681\/ASN.2008050513","article-title":"Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.","volume":"19","author":"Zeisberg","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0002-9440(10)61150-9","article-title":"Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells.","volume":"160","author":"Zeisberg","year":"2002","journal-title":"Am. J. Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1681\/ASN.2010080793","article-title":"Mechanisms of tubulointerstitial fibrosis.","volume":"21","author":"Zeisberg","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/01.HYP.0000085649.28268.DF","article-title":"Salt-sensitive hypertension after exposure to angiotensin is associated with an inability to upregulate renal epoxygenases.","volume":"42","author":"Zhao","year":"2003","journal-title":"Hypertension"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T00:13:29Z","timestamp":1498781609000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,30]]},"references-count":43,"alternative-id":["10.3389\/fphar.2017.00406"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00406","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,30]]},"article-number":"406"}}